Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
6/9/2025
Kelun-Biotech Secures US$250M in Upsized HK Share Placement
6/9/2025
Everest Presents Positive Results from Phase 1b/2a Trial of EVER001 fo...
6/9/2025
Sihuan's Chinese NDA for Breast Cancer Drug Bireociclib Accepted
6/9/2025
China Exempts U.S. Drugs & Medical Supplies from Retaliatory Tariffs
6/9/2025
CDE Solicits Comments on Draft Guidance on Post-Approval Change Manage...
6/9/2025
YolTech's YOLT‑101 Wins FDA IND Clearance as China Licensee Salubris ...
6/9/2025
Livzon's siRNA Candidate YJH‑012 Approved for Clinical Entry in China
6/9/2025
Argo's siRNA Candidate BW‑00163 Enters Phase 2 for Hypertension
6/7/2025
Recent Executive Moves
6/7/2025
QureBio Secures ~CNY 100M in Series C1 Financing to Advance BsAb Thera...
6/6/2025
Zelgen and Merck Partner to Launch China's First rhTSH Therapy for Pos...
6/6/2025
Beigene's BGB‑16673 Enters Phase 1b Trial for Chronic Urticaria in Ch...
6/6/2025
Qilu Launches Phase III Trial of QL1706 + Bevacizumab
6/6/2025
BMS's Reblozyl Approved in China for Lower‑Risk MDS‑Related Anemia
6/6/2025
AstraZeneca's Imfinzi Approved in China for LS‑SCLC
6/6/2025
Keymed Launches First-in-Human Trial of CM518D1
6/6/2025
AbbVie's Rinvoq (Upadacitinib) Gains Approval in China for Giant Cell ...
6/6/2025
Kelun‑Biotech Initiates Phase II Trial of PTK7‑Targeted ADC SKB518 i...
6/6/2025
Akeso's Cadonilimab Gains First-Line Approval in Cervical Cancer in Ch...
6/5/2025
CSPC Receives Chinese Approval for Cobamamide Capsules to Treat Anemia
6/5/2025
Cullinan Secures Global Rights to Genrix's Velinotamig
6/5/2025
NHSA Issues Notice to Enhance Drug Pricing and Procurement Credit Eval...
6/5/2025
Ascletis's Denifanstat Shows Promising Results in Phase III Acne Trial
6/4/2025
Biocytogen and CTTQ Receive IND Approval in China for Next-Gen Anti-IG...
6/4/2025
China Approves First Homegrown 9-Valent HPV Vaccine
6/4/2025
Sagimet and Ascletis Report Positive Phase 3 Results for Denifanstat i...
6/4/2025
China's Child Health Improves: NHC Official
6/3/2025
BioAge Partners with JiKang Thera for APJ Agonist After Obesity Drug S...
6/3/2025
Akeso Stumbles as FDA Sets Higher Bar for Ivonescimab Approval
6/3/2025
Leads Biolabs' LBL-024 Shows Promising Results in EP-NEC Treatment
Page:
1
/
51
Total number of articles:
1510
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit